$BRO

JOHNSON JOIA M purchased $50K of BRO (indirect holdings)

JOHNSON JOIA M purchased 860 indirectly-held shares of BROWN & BROWN, INC. (BRO) at $58.05 on 2026-06-09.

Original reporting
SEC EDGAR · JOHNSON JOIA M
Published Jun 10, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 10, 2026, 9:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BRO
Bullish
high confidence
Mentioned
$BRO
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BROBullishLow
01

Why it matters

The filing discloses an open-market purchase (code P) of 860 shares at $58.05, with holdings after the trade reported as 860 shares; no 10b5-1 plan is indicated.

02

Market read

Traders may treat this as a minor positive sentiment datapoint, but it is not a fundamental catalyst.

03

What to watch

The transaction size (~$50k) is small relative to typical institutional flows, so any impact is likely sentiment-only rather than a catalyst.

Relevance 4/10Novelty 8/10Timing: Filed 2026-06-10 (covers purchase dated 2026-06-09)

Background

The article reports a director’s SEC Form 4 insider transaction for Brown & Brown, Inc. (BRO).

Company-level read

Ticker impact

$BROBullishHigh confidence
Context

Brown & Brown director Johnson Joia M filed an SEC Form 4 for an open-market purchase of 860 shares at $58.05 on 2026-06-09.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to sentiment/flow rather than new fundamentals.

Evidence & confidence

This is a routine insider Form 4 with modest size (~$50k) and no 10b5-1 plan disclosed; it signals personal conviction but does not introduce new company-specific operating or financial information.

Market effects

No clear sector read-through; this is company-specific insider activity without broader industry signal.

None indicated.

None indicated.

Counterpoint

Insider buys can be driven by diversification, liquidity needs, or routine compensation/plan mechanics; without a 10b5-1 plan, timing is still not necessarily predictive.

Key entities

  • BROWN & BROWN, INC.

    Subject of the SEC Form 4 insider transaction (BRO).

  • JOHNSON JOIA M

    Director who purchased 860 shares via open-market purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BROMed

Brown & Brown gets bullish rating as Oppenheimer starts coverage of P&C brokers (BRO:NYSE)

Oppenheimer initiated coverage of property & casualty insurance brokers, rating Brown & Brown (BRO) Outperform and Arthur J. Gallagher (AJG) Sector Perform. The firm expects BRO's organic growth to improve, driven by the Accession acquisition, while noting durable growth prospects for brokerages. However, AJG's margin improvement is expected to stall due to integration and industry challenges.

$BROMedAI 8/10

Winners And Losers Of Q2: Baldwin Insurance Group (NASDAQ:BWIN) Vs The Rest Of The Insurance Brokers Stocks

Ryan Specialty beat estimates but fell 11.1% to $39.20. Brown & Brown (BRO) reported $1.68B revenue, up 30.4% YoY, missing estimates by 2.5%, and dropped 3.4% to $67.32. Arthur J. Gallagher (AJG) reported $4.00B revenue, up 24.3% YoY, missing estimates by 0.5%, and fell 3.3% to $248.05. Marsh (MRSH) reported $7.40B revenue, up 6.2% YoY, beating estimates by 1.8%, and dropped 1.2% to $179.91.

$BROMed

Why Are Brown & Brown (BRO) Shares Soaring Today

Brown & Brown (NYSE: BRO) shares rose about 5% after the company reported Q2 results. Revenue increased 30.4% year over year to $1.68B, slightly below analysts’ $1.72B estimate. Adjusted EPS was $1.07, in line with expectations, driving investor focus on strong growth despite the revenue miss.

$BROMed

Brown & Brown Q2 Earnings Call Highlights

Brown & Brown (NYSE:BRO) discussed Q2 results on its earnings call. CFO Andy Watts said Retail revenue rose 35.9% mainly from acquisitions, while Retail organic growth was pressured by a pharmacy consulting business and a litigation-related organic revenue adjustment. Specialty Distribution total revenue rose 28.1% on Accession, with EBITDAC margin down to 42.7%. BRO expects H2 Retail organic growth excluding contingents of 1.5% to 2.5% and Specialty 2% to 4%, and reaffirmed $30M-$40M integratio